Introduction to ZNF836, A Potential Drug Target (G162962)

Target Name: ZNF836

NCBI ID: G162962

ZNF836

Other Name(s): ZN836_HUMAN | zinc finger protein 836 | Zinc finger protein 836

Introduction to ZNF836, A Potential Drug Target

ZNF836, an abbreviation for Zinc Finger Protein 836, is a promising drug target that has shown significant potential in the field of biomedical research. This article will delve into the various aspects of ZNF836, including its structure, function, and potential applications as a drug target or biomarker.

Structure of ZNF836

ZNF836 belongs to the zinc finger protein family, which is characterized by protein domains that bind specifically to DNA. These zinc finger motifs contain a coordination site for a zinc ion, which plays a crucial role in their stability and function. The specific structure of ZNF836 consists of five C2H2-type zinc fingers, which are responsible for its DNA-binding activity. These zinc fingers fold into a compact globular domain, allowing ZNF836 to interact selectively with DNA sequences, known as binding sites.

Function of ZNF836

The primary function of ZNF836 is to regulate gene expression by binding to specific DNA sequences. Through its zinc finger domains, ZNF836 recognizes and binds to specific DNA sequences in the promoter regions of target genes. This binding enables ZNF836 to either activate or repress the transcription of these genes, depending on the biological context. The precise regulation of gene expression by ZNF836 is crucial for maintaining cellular homeostasis and controlling various biological processes.

Role of ZNF836 as a Drug Target

Given its involvement in gene regulation, ZNF836 has emerged as a potential drug target for various diseases. Manipulating the activity of ZNF836 can result in the modulation of gene expression, making it a promising avenue for therapeutic intervention. For instance, in cancer research, targeting ZNF836 could inhibit the transcription of oncogenes, which promote tumor growth. Conversely, activating ZNF836 could enhance the expression of tumor-suppressor genes, aiding in the suppression of cancerous proliferation.

Moreover, ZNF836 has also been implicated in neuronal development and neurodegenerative diseases. Targeting ZNF836 could influence the expression of genes crucial for neurodevelopment and potentially offer novel therapeutic strategies for conditions like Alzheimer's disease or Parkinson's disease. Further research and understanding of the complex regulatory mechanisms involving ZNF836 are necessary to harness its potential as a drug target effectively.

ZNF836 as a Biomarker

In addition to its potential as a drug target, ZNF836 has shown promise as a biomarker for several diseases. Biomarkers are measurable indicators that provide critical information about disease progression, treatment response, or prognosis. Elevations or alterations in ZNF836 levels have been observed in various diseases, including cancer, cardiovascular disorders, and neurological conditions.

For example, increased expression of ZNF836 in certain cancers, such as breast cancer or colorectal cancer, has been associated with poor prognosis and aggressive tumor behavior. Monitoring ZNF836 levels could potentially aid in early detection, risk assessment, and treatment planning for these malignancies.

Similarly, ZNF836 has been implicated in cardiovascular diseases, including atherosclerosis and hypertension. Abnormal expression of ZNF836 in these conditions suggests its potential as a biomarker for assessing disease severity or predicting cardiovascular events. Furthermore, in neurodegenerative disorders, alterations in ZNF836 levels have been reported, potentially serving as a biomarker for disease progression or response to therapy.

Conclusion

ZNF836, a zinc finger protein, holds great promise as both a drug target and a biomarker for various diseases. Its structure, characterized by zinc finger domains, enables selective DNA binding and regulation of gene expression. Manipulating the activity of ZNF836 could have significant therapeutic implications, particularly in cancer and neurodegenerative diseases.

Furthermore, the potential of ZNF836 as a biomarker provides a valuable tool for disease diagnosis, prognosis, and treatment monitoring. Further research and understanding of the intricate molecular mechanisms involving ZNF836 are necessary to fully exploit its potential as a therapeutic target and biomarker in various disease contexts. The future of biomedical research holds exciting possibilities for harnessing the power of ZNF836 in improving human health.

Protein Name: Zinc Finger Protein 836

Functions: May be involved in transcriptional regulation

The "ZNF836 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF836 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets